Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine-Reference-Cited by-同舟云学术

Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine

Published:2000-05 Issue:2 Volume:109 Page:388-395
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Braess Jan,Wegendt Christine,Jahns-Streubel Gerlinde,Kern Wolfgang,Keye Susan,Unterhalt Michael,Schleyer Eberhardt,Hiddemann Wolfgang

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2000.02056.x/fullpdf

Reference29 articles.

1. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects;Anonymous (;Journal of the American Medical Association,1997

2. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells;Bhalla;Leukemia,1988

3. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts;Bhalla;Blood,1991

4. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia;Boos;Medical and Pediatric Oncology,1996

5. Detection and determination of the major metabolites of [3H] cytosine arabinoside by high-performance liquid chromatography;Braess;Journal of Chromatography B Biomedical Applications,1996

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine;Pediatric Hematology and Oncology;2023-01-10

2. Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence;Cancer Discovery;2021-01-26

3. Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial;Blood Advances;2020-01-24

4. Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells;Molecules;2017-03-21

5. Elacytarabine: lipid vector technology under investigation in acute myeloid leukemia;Expert Review of Hematology;2013-02